Could Psychedelic Treatments Change Mental Health Care?

May 19, 2026

👉 Watch the full interview here:

NRX Pharma CEO Dr. Jonathan Javitt discusses breakthrough mental health treatments, ketamine therapy, PTSD, severe depression, FDA developments, and the growing role of neuroplastic therapies in patient care.

The full interview also covers veterans’ mental health, psychedelic medicine, clinical progress, and the future of psychiatric treatment.

#MentalHealth #PTSD #Ketamine #DepressionTreatment #Biotech #HealthcareInnovation #PsychedelicMedicine #Investing

Could Psychedelic Treatments Change Mental Health Care?

Recommended

Aeries Technology Launches AI Platform to Transform Global Enterprise Operations

YY Group Joins Singapore Hotel Association to Expand Hospitality Network

Medicus Pharma Advances Skinject Toward FDA Pivotal Trial for Skin Cancer

Virtuix Expands VR Defense Training and Consumer Gaming With Omni Platform

Lost Soldier Oil & Gas Targets Massive Wyoming Natural Gas Discovery

FreeCast Aims to Become the Spotify of Television and Streaming

Could Psychedelic Treatments Change Mental Health Care?

Recommended

Aeries Technology Launches AI Platform to Transform Global Enterprise Operations

YY Group Joins Singapore Hotel Association to Expand Hospitality Network

Medicus Pharma Advances Skinject Toward FDA Pivotal Trial for Skin Cancer

Virtuix Expands VR Defense Training and Consumer Gaming With Omni Platform

Lost Soldier Oil & Gas Targets Massive Wyoming Natural Gas Discovery

FreeCast Aims to Become the Spotify of Television and Streaming

Share

Investor Accreditation

For Individuals

Thank You!